Hikari Power’s ProQR Therapeutics PRQR Stock Holding History

Hikari Power’s Portfolio PRQR Stock Details PRQR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-24,144	Closed	-$121K	–	101
2017 Q1	$121K	Buy	+24,144	New	+$106K	0.02%	68

Other funds holding PRQR

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Hikari Power's PRQR Position: Q2 2017 in Review

Hikari Power sold out of ProQR Therapeutics (PRQR) in Q2 2017, closing a stake of 24,144 shares — an estimated $121K sold.

Hikari Power first reported a position in PRQR in Q1 2017 and held it in 1 quarter. The position peaked at $121K in Q1 2017. 18 funds tracked by Wall St. Rank hold PRQR as of Q2 2017.

Hikari Power reported no remaining ProQR Therapeutics position as of Q2 2017 after selling out during the quarter.
Hikari Power sold 24,144 ProQR Therapeutics shares in Q2 2017, an estimated $121K.
Hikari Power first reported a position in ProQR Therapeutics in Q1 2017 and held it in 1 quarter.
Hikari Power's ProQR Therapeutics position peaked at $121K in Q1 2017.
18 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q2 2017.

Based on Hikari Power's 13F filing for Q2 2017, filed 9 Aug 2017.